Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 6/2007

01-08-2007 | Original Paper

Predicting quality of life impairment in chronic schizophrenia from cognitive variables

Auteur: Michael S. Ritsner

Gepubliceerd in: Quality of Life Research | Uitgave 6/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Background The aim of this study was to see whether and how cognition deficit predicts quality of life impairments in schizophrenia patients. Method The Computerized Cambridge Automated Neuropsychological Test Battery, the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) and the Quality of Life Scale (QLS) were used to assess 62 patients with chronic schizophrenia. Step-wise multiple regression analysis was used in order to determine cognitive variables that would predict the scores of each Q-LES-Q and QLS domain scores. Results Regression analysis revealed a significant association of the cognitive deficits with both general and domain-specific quality of life impairment measured with Q-LES-Q and QLS. Deficits in executive functions, visual sustained attention, memory and motor skills have been found to be valid predictors both before and after controlling for the severity of symptoms, emotional distress, side effects, age, education, and illness duration. Conclusions This study suggests that deficits in executive functioning, attention, memory and motor skills substantially contributes to predicting impairments across a wide range of HRQL domains, and, consequently, to quality of life appraisal in schizophrenia. Cognitive predictors cannot be attributed to illness-related and background variables. It can be concluded that, when aiming at the improvement of quality of life in schizophrenia patients, cognitive functioning should be targeted.
vorige artikel Effect of trauma on quality of life as mediated by mental distress and moderated by coping and social support among postconflict displaced Ethiopians
volgende artikel Sense of coherence predicts change in life satisfaction among home-living residents in the community with mental health problems: a 1-year follow-up study
Literatuur
1.
Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. The New England Journal of Medicine, 334, 835–840.PubMedCrossRef
2.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273, 59–65.PubMedCrossRef
3.
Ritsner, M. S. (2007). The distress/protection vulnerability model of the quality of life impairment syndrome: Current evidence and new directions for research. In M. S. Ritsner & A. G. Awad (Eds.), Quality of life impairment in Schizophrenia, mood and anxiety disorders. New perspectives on research and treatment (pp. 3–19). Springer.
4.
Keefe, R. S., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., Adler, L. W., Manschreck, T. C., Swartz, M., Rosenheck, R., Perkins, D. O., Walker, T. M., Stroup, T. S., McEvoy, J. P., & Lieberman, J. A. (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31, 2033–2046.PubMedCrossRef
5.
Heslegrave, R. J., Awad, A. G., & Voruganti, L. N. (1997). The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. Journal of Psychiatry and Neuroscience, 22, 235–243.PubMed
6.
Addington, J., & Addington, D. (2002). Cognitive functioning in first-episode schizophrenia. Journal of Psychiatry and Neuroscience, 27, 188–192.PubMed
7.
Kaiser, W. (2000). Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life. British Journal of Psychiatry, 176, 92–93.PubMedCrossRef
8.
Aksaray, G., Oflu, S., Kaptanoglu, C., & Bal, C. (2002). Neurocognitive deficits and quality of life in outpatients with schizophrenia. Progress in Neuro-psychopharmacology & Biological Psychiatry, 26, 1217–1219.CrossRef
9.
Sota, T. L., & Heinrichs, R. W. (2004). Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Comprehensive Psychiatry, 45, 415–421.PubMedCrossRef
10.
Alptekin, K., Akvardar, Y., Kivircik Akdede, B. B., et al. (2005). Is quality of life associated with cognitive impairment in schizophrenia?. Progress in Neuro-psychopharmacology and Biological Psychiatry, 29, 239–244.PubMedCrossRef
11.
Wegener, S., Redoblado-Hodge, M. A., Lucas, S., et al. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. The Australian and New Zealand Journal of Psychiatry, 39, 487–492.PubMedCrossRef
12.
Awad, A. G., Voruganti, L. N., & Heslegrave, R. J. A. (1997). Conceptual model of quality of life in schizophrenia: Description and preliminary drugs, relationships to objective psychopathology, quality of life, clinical validation. Quality of Life Research, 6, 21–26.PubMedCrossRef
13.
Ritsner, M., Modai, I., Endicott, J., Rivkin, O., Nechamkin, Y., Barak, P., Goldin, V., & Ponizovsky, A. (2000). Differences in quality of life domains, psychopathological and psychosocial factors in psychiatric patients. Journal of Clinical Psychiatry, 61, 880–889.PubMedCrossRef
14.
Ritsner, M., Gibel, A., & Ratner, Y. (2006). Determinants of changes in perceived quality of life in the course of Schizophrenia. Quality of Life Research, 15, 515–526.PubMedCrossRef
15.
Fitzgerald, P. B., Williams, C. L., Corteling, N., et al. (2001). Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica, 103, 387–392 .PubMedCrossRef
16.
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit scale. Schizophrenia Bulletin, 10, 388–398.PubMed
17.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. Washington, DC.
18.
Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacology Bulletin, 29, 321–326.PubMed
19.
Ritsner, M., Modai, I., Kurs, R., et al. (2002). Subjective quality of life measurements in severe mental health patients: Measuring quality of life of psychiatric patients: Comparison two questionnaires. Quality Life Research, 11, 553–561.CrossRef
20.
Sahakian, B. J., & Owen, A. M. (1992). Computerized assessment in neuropsychiatry using CANTAB: Discussion paper. Journal of the Royal Society of Medicine, 85, 399–402.PubMed
21.
Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers. Dementia, 5, 266–281.PubMedCrossRef
22.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.PubMed
23.
Ritsner, M., Rabinowitz, J., & Slyuzberg, M. (1995). The Talbieh Brief Distress Inventory: A brief instrument to measure psychological distress among immigrants. Comprehensive Psychiatry, 36, 448–453.PubMedCrossRef
24.
Chouinard, G., Ross-Chouinard, A., Annale, L., et al. (1980). Extrapyramidal Symptom Rating Scale. Canadian Journal of Neurological Sciences, 7, 233.
25.
White, L., Harvey, P. D., Opler, L., Lindenmayer, J. P. & PANSS Study Group. (1997). Empirical assessment of the factorial structure of clinical symptoms in Schizophrenia. Psychopathology, 30, 263–274.
26.
Ritsner, M., Modai, I., & Ponizovsky, A. (2002). The Talbieh brief distress inventory: Validation for use with psychiatric patients. Comprehensive Psychiatry, 2, 144–163.
27.
Hintze, J. L., NCSS & PASS. (2001). Statistical system for Windows. User’s guide. number cruncher statistical systems, number cruncher statistical systems, Kaysville. Utah. www.NCSS.com.
28.
Awad, A. G., & Voruganti, L. N. (2004). Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs, 18, 877–893.PubMedCrossRef
29.
Lambert, M., & Naber, D. (2004). Current issues in schizophrenia: Overview of patient acceptability, functioning capacity and quality of life. CNS Drugs, 2 (18 Suppl), 5–17.CrossRef
30.
Ritsner, M., & Kurs, R. (2006). Quality-of-life impairment in severe mental illness: Focus on Schizoaffective disorders. In William H. Murray (ed.), Schizoaffective disorder: New research. (pp. 69–107). NY: NOVA Publishers.
31.
Erlenmeyer-Kimling, L., Rock, D., Roberts, S. A., Janal, M., Kestenbaum, C., Cornblatt, B., & Adamo, U. H. (2000). Gottesman II. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York High-Risk Project. The American Journal of Psychiatry, 157, 1416–1422.PubMedCrossRef
32.
Zalla, T., Joyce, C., Szoke, A., Schurhoff, F., Pillon, B., Komano, O., Perez-Diaz, F., Bellivier, F., Alter, C., Dubois, B., Rouillon, F., Houde, O'., & Leboyer, M. (2004). Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Research, 21, 207–217.CrossRef
33.
Hoff, A. L., Svetina, C., Maurizio, A. M., Crow, T. J., Spokes, K., & DeLisi, L. E. (2005). Familial cognitive deficits in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 133, 43–49.CrossRef
34.
Saperstein, A. M., Fuller, R. L., Avila, M. T., Adami, H., McMahon, R. P., Thaker, G. K., & Gold, J. M. (2006). Spatial working memory as a cognitive endophenotype of schizophrenia: Assessing risk for pathophysiological dysfunction. Schizophrenia Bulletin, 32, 498–506.PubMedCrossRef
35.
Chen, W. J., & Faraone, S. V. (2000). Sustained attention deficits as markers of genetic susceptibility to schizophrenia. American Journal of Medical Genetics, 97, 52–57.PubMedCrossRef
36.
Liu, S. K., Chiu, C. H., Chang, C. J., Hwang, T. J., Hwu, H. G., & Chen, W. J. (2002). Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. The American Journal of Psychiatry, 159, 975–982.PubMedCrossRef
37.
Bozikas, V. P., Andreou, C., Giannakou, M., Tonia, T., Anezoulaki, D., Karavatos, A., Fokas, K., & Kosmidis, M. H. (2005). Deficits in sustained attention in schizophrenia but not in bipolar disorder. Schizophrenia Research, 78, 225–233.PubMedCrossRef
38.
Stone, W. S., Faraone, S. V., Seidman, L. J., et al. (2001). Concurrent validation of schizotaxia: A pilot study. Biological Psychiatry, 50, 434–440.PubMedCrossRef
39.
Tsuang, M. T., Stone, W. S., Gamma, F., & Faraone, S. V. (2003). Schizotaxia: Current status and future directions. Current Psychiatry Reports, 5, 128–134.PubMedCrossRef
40.
Erickson, D. H., Beiser, M., Iacono, W. G., et al. (1989). The role of social relationships in the course of first-episode schizophrenia and affective psychosis. The American Journal of Psychiatry, 146, 1456–1461.PubMed
41.
Bechdolf, A., Pukrop, R., Kohn, D., et al. (2005). Subjective quality of life in subjects at risk for a first episode of psychosis: A comparison with first episode schizophrenia patients and healthy controls. Schizophrenia Research, 79, 137–143.PubMedCrossRef
Metagegevens
Titel
Predicting quality of life impairment in chronic schizophrenia from cognitive variables
Auteur
Michael S. Ritsner
Publicatiedatum
01-08-2007
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 6/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9195-3

Andere artikelen Uitgave 6/2007

Quality of Life Research 6/2007 Naar de uitgave

Original Paper

Psychometric properties of the Minnesota Living with Heart Failure—Brazilian version—in the elderly

OriginalPaper

Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report

Original Paper

Health related quality of life in different states of breast cancer

OriginalPaper

Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting

Original Paper

US and UK versions of the EQ-5D preference weights: Does choice of preference weights make a difference?

Original Paper

Differential item functioning impact in a modified version of the Roland–Morris Disability Questionnaire